Drug-price reforms need not affect research on rare diseases – or the Canadians who have them

26 August 2019 - On 9 August, the Patented Medicine Prices Review Board of Canada announced new drug-pricing regulations for ...

Read more →

Companies file suit in Canada challenging new rules to lower drug prices

23 August 2019 - Five pharmaceutical companies said on Friday they have filed a complaint in a Canadian court challenging ...

Read more →

Updated procedure and submission guidelines for the CADTH Common Drug Review

22 August 2019 - The Procedure and Submission Guidelines for the CADTH Common Drug Review has been updated with the ...

Read more →

Empirical evidence supports critics of Patented Medicine Prices Review Board regulations

21 August 2019 - Canadian Health Policy Institute, a Toronto-based private-sector think-tank established in 2012, has published several studies that bolster ...

Read more →

Bring in pharmacare now, health experts ask federal leaders

15 August 2019 - Signatories include professors of medicine, pharmacy, nursing, economics, political science and law. ...

Read more →

What will PMPRB drug pricing changes mean for plan sponsors?

15 August 2019 - Private plan sponsors can expect to see lower drug prices resulting from recent changes to the ...

Read more →

Canadians benefitting from substantially lower generic drug prices

14 August 2019 - Latest agreement between public payers and the Canadian generic industry closes gap with international prices. ...

Read more →

Ottawa’s move to cut drug prices may lead to fewer new launches, less R&D

13 August 2019 - Health Canada is fundamentally changing how prescription drugs are priced in Canada.  ...

Read more →

Proposed new drug regulations will hurt all Canadians — and Ottawa has been warned

13 August 2019 - Changes which aim to make prescriptions more affordable could shut off entry of new drugs. ...

Read more →

Canadian drug price regulator may be flexible on rare diseases

14 August 2019 - Canada’s patented drug price regulator, set to gain new powers next year, may be “more forgiving” in ...

Read more →

Federal changes to drug prices win praise from patient advocates but spark industry warnings

10 August 2019 - A federal government move to lower drug prices is winning praise from some patient advocates but ...

Read more →

Drug policy experts accuse industry and patient groups of 'fearmongering' with concerns about new drug pricing rule

11 August 2019 - Industry groups and patient advocates are raising concerns about the federal government’s new drug-pricing rules, claiming ...

Read more →

Details of Canada's biggest drug pricing overhaul in decades

10 August 2019 - The Canadian government finalized the biggest overhaul to its drug pricing regime since 1987 on Friday, ...

Read more →

Government of Canada announces changes to lower drug prices and lay the foundation for National Pharmacare

9 August 2019 - Today, the Government of Canada announced the final amendments to the Patented Medicines Regulations.  ...

Read more →

Knight Therapeutics and pan-Canadian Pharmaceutical Alliance reach agreement for Probuphine for opioid dependence

6 August 2019 - AB, SK and NIHB are the first public drug plans to fund Probuphine recognising benefits of new ...

Read more →